AGA Clinical Practice Guidelines on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease

AGA Technical Review on the Medical Management of Moderate to Severe Luminal and Perianal Fistulizing Crohn’s Disease

(2021) Siddharth Singh et al.   GASTROENTEROLOGY

Addition of azathioprine to the switch of anti-TNF in patients with IBD in clinical relapse with undetectable anti-TNF trough levels and antidrug antibodies: a prospective randomised trial

(2020) Xavier Roblin et al.   GUT

Effects of Race and Ethnicity on Diagnosis and Management of Inflammatory Bowel Diseases

(2020) Edward L. Barnes et al.   GASTROENTEROLOGY

Withdrawal of thiopurines in Crohn’s disease treated with scheduled adalimumab maintenance: a prospective randomised clinical trial (DIAMOND2)

(2019) Tadakazu Hisamatsu et al.   JOURNAL OF GASTROENTEROLOGY

Natural disease course of Crohn’s disease during the first 5 years after diagnosis in a European population-based inception cohort: an Epi-IBD study

(2018) Johan Burisch et al.   GUT

Decreasing Risk of First and Subsequent Surgeries in Patients With Crohn's Disease in England From 1994 through 2013

(2018) Nicholas E. Burr et al.   Clinical Gastroenterology and Hepatology

Pharmacokinetic drug evaluation of budesonide in the treatment of Crohn’s disease

(2017) Lukasz Kwapisz et al.   Expert Opinion on Drug Metabolism & Toxicology

American Gastroenterological Association Institute Technical Review on the Role of Therapeutic Drug Monitoring in the Management of Inflammatory Bowel Diseases

(2017) Niels Vande Casteele et al.   GASTROENTEROLOGY

American Gastroenterological Association Institute Guideline on Therapeutic Drug Monitoring in Inflammatory Bowel Disease

(2017) Joseph D. Feuerstein et al.   GASTROENTEROLOGY

Crohn's disease

(2017) Joana Torres et al.   LANCET

Crohn Disease: Epidemiology, Diagnosis, and Management

(2017) Joseph D. Feuerstein et al.   MAYO CLINIC PROCEEDINGS

Perianal fistulizing Crohn's disease: pathogenesis, diagnosis and therapy

(2017) Julián Panés et al.   Nature Reviews Gastroenterology & Hepatology

Improvements in the Long-Term Outcome of Crohn’s Disease Over the Past Two Decades and the Relation to Changes in Medical Management: Results from the Population-Based IBDSL Cohort

(2016) Steven F G Jeuring et al.   AMERICAN JOURNAL OF GASTROENTEROLOGY

Development of an index to define overall disease severity in IBD

(2016) Corey A Siegel et al.   GUT

Early combined immunosuppression for the management of Crohn's disease (REACT): a cluster randomised controlled trial

(2015) Reena Khanna et al.   LANCET

Conceptual and Technical Challenges in Network Meta-analysis

(2013) Andrea Cipriani et al.   ANNALS OF INTERNAL MEDICINE

The AGA Institute Process for Developing Clinical Practice Guidelines Part One: Grading the Evidence

(2013) Shahnaz Sultan et al.   Clinical Gastroenterology and Hepatology

Early Administration of Azathioprine vs Conventional Management of Crohn's Disease: A Randomized Controlled Trial

(2013) Jacques Cosnes et al.   GASTROENTEROLOGY

Risk of Lymphoma in Patients With Ulcerative Colitis Treated With Thiopurines: A Nationwide Retrospective Cohort Study

(2013) Nabeel Khan et al.   GASTROENTEROLOGY

Risk of Surgery for Inflammatory Bowel Diseases Has Decreased Over Time: A Systematic Review and Meta-analysis of Population-Based Studies

(2013) Alexandra D. Frolkis et al.   GASTROENTEROLOGY

Maintenance of Remission Among Patients With Crohn's Disease on Antimetabolite Therapy After Infliximab Therapy Is Stopped

(2011) Edouard Louis et al.   GASTROENTEROLOGY

Infliximab, Azathioprine, or Combination Therapy for Crohn's Disease

(2010) Jean Frédéric Colombel et al.   NEW ENGLAND JOURNAL OF MEDICINE

Early combined immunosuppression or conventional management in patients with newly diagnosed Crohn's disease: an open randomised trial

(2008) Geert D'Haens et al.   LANCET